Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)

Trial Profile

Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Imatinib (Primary) ; Antineoplastics
  • Indications Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Acronyms STAR ReGISTry
  • Most Recent Events

    • 16 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 16 Dec 2016 Planned End Date changed from 31 Dec 2017 to 31 Dec 2019.
    • 07 Jun 2016 Results (n=541) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top